A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE FINDING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PADSEVONIL AS ADJUNCTIVE TREATMENT OF FOCAL-ONSET SEIZURES IN ADULT SUBJECTS WITH DRUG-RESISTANT EPILEPSY
Clinical Trial Grant
Administered By
Neurology, Epilepsy and Sleep
Awarded By
UCB Pharma, Inc.
Start Date
May 18, 2018
End Date
December 31, 2020
Administered By
Neurology, Epilepsy and Sleep
Awarded By
UCB Pharma, Inc.
Start Date
May 18, 2018
End Date
December 31, 2020